Page 104 - GTM-3-1
P. 104

Global Translational Medicine                                    Anergy in Leishmania-associated malignancy



              Chronic inflammation may be a predisposing factor for   Consent for publication
            the development of human neoplastic process. In addition,
            risk factors for leishmaniasis (immunosuppression), such   Written consent was obtained from the patient to publish
            as parasite-specific anergy, may promote the development   his data and images. Efforts had been made by the authors
            of skin cancer.  Although there is no known time   to mask any identifying information and facial features of
                         9,16
            interval between resolution of infection and malignant   the patient that may appear in the paper.
                        8
            transformation,  both may be present simultaneously, even   Availability of data
            during active infection.
                                                               Not applicable.
            4. Conclusion                                      References

            In many cases of leishmaniasis that have been satisfactorily
            cured, cancers may develop in the prior old, healed   1.   Sasidharan S, Saudagar P. Leishmaniasis: Where are we and
            lesions, but can also occur in active leishmaniasis   where are we heading? Parasitol Res. 2021;120(5):1541-1554.
            lesions in immunocompetent patients as well as in      doi: 10.1007/s00436-021-07139-2
            immunocompromised cases. The current case underlines   2.   Lopez Y, Arana B,  Rizzo N, Duran E, Acosta-Serrano Á,
            the role of a weakening host immune response as a result of   Mendizabal-Cabrera R. A neglected among the neglected:
            diffuse cutaneous leishmaniasis in the development of SCC.   A review of cutaneous leishmaniasis in Guatemala. Trans R
            Such postulation points to and corroborates the involvement   Soc Trop Med Hyg. 2023;117(9):609-616.
            of anergy, a condition probably caused by parasite-induced      doi: 10.1093/trstmh/trad024
            suppression of the immune response, in the co-occurrence
            of leishmaniasis and skin malignancy development. The   3.   Bañuls AL, Bastien P, Pomares C, Arevalo J, Fisa R, Hide M.
                                                                  Clinical pleiomorphism in human leishmaniases, with
            role of the host immune response in the development of   special mention of asymptomatic infection. Clin Microbiol
            the disease is highlighted by the development of SCC.   Infect. 2011;17(10):1451-1461.
            Anergy, probably related to a parasite-induced suppression
            of  the immune  response,  may  be  a common  factor      doi: 10.1111/j.1469-0691.2011.03640.x
            linking leishmaniasis and malignancy. Therefore, it is of   4.   Pinheiro RO, Pinto EF, Benedito AB, Lopes UG, Rossi-
            utmost clinical significance to consider malignancy in the   Bergmann B. The T-cell anergy induced by  Leishmania
            differential diagnosis of rapidly growing or difficult-to-treat   amazonensis antigens is related with defective antigen
            lesions for in patients with active leishmaniasis.    presentation and apoptosis.  An Acad Bras Cienc.
                                                                  2004;76(3):519-527.
            Acknowledgments                                       doi: 10.1590/s0001-37652004000300006
            None.                                              5.   Saidi N, Blaizot R, Prévot G, et al. Clinical and immunological
                                                                  spectra of human cutaneous leishmaniasis in North Africa
            Funding                                               and French Guiana. Front Immunol. 2023;14:1134020.
            None.                                                 doi: 10.3389/fimmu.2023.1134020
                                                               6.   Rashidi S, Fernández-Rubio C, Manzano-Román R,  et al.
            Conflict of interest                                  Potential therapeutic targets shared between leishmaniasis
            The authors declare that they have no competing interest.  and cancer. Parasitology. 2021;148(6):655-671.
                                                                  doi: 10.1017/S0031182021000160
            Author contributions
                                                               7.   Wysong A. Squamous-cell carcinoma of the skin. N Engl J
            Conceptualization: Andrés Tirado-Sánchez, Alexandro   Med. 2023;388:2262-2273.
               Bonifaz                                            doi: 10.1056/NEJMra2206348
            Investigation:  Andrés  Tirado-Sánchez,  Sebastián
               Hernández-Gómez                                 8.   Carrillo-Larco RM,  Acevedo-Rodriguez JG,  Altez-
            Writing – original draft: Andrés Tirado-Sánchez       Fernandez C, Ortiz-Acha K, Ugarte-Gil C. Is there an
                                                                  association  between  cutaneous  leishmaniasis  and  skin
            Writing – review & editing: Andrés Tirado-Sánchez,    cancer? A systematic review. Wellcome Open Res. 2019;4:110.
               Alexandro Bonifaz, Sebastián Hernández-Gómez
            Ethics approval and consent to participate            doi: 10.12688/wellcomeopenres.15367.1
                                                               9.   Morsy TA. Cutaneous leishmaniasis predisposing to human
            Written consent was obtained from the patient to      skin cancer: Forty years local and regional studies. J Egypt
            participate in the study.                             Soc Parasitol. 2013;43(3):629-648.


            Volume 3 Issue 1 (2024)                         4                        https://doi.org/10.36922/gtm.2281
   99   100   101   102   103   104   105   106   107   108